We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMR icon
1301
Nomura Holdings
NMR
$28.1B
$73K ﹤0.01%
14,226
-1,366
-9% -$6.59K
DAR icon
1302
Darling Ingredients
DAR
$9.28B
$72K ﹤0.01%
2,574
+709
+38% +$15.8K
FLR icon
1303
Fluor
FLR
$6.89B
$72K ﹤0.01%
3,840
+59
+2% +$1.07K
NEWR
1304
DELISTED
New Relic, Inc.
NEWR
$72K ﹤0.01%
1,114
PUB
1305
DELISTED
PUBLICIS SA ADS (1 ADS = 1C0M)
PUB
$72K ﹤0.01%
6,472
+5,716
+756% +$63.6K
MGPI icon
1306
MGP Ingredients
MGPI
$400M
$71K ﹤0.01%
1,468
+395
+37% +$18.5K
NWE icon
1307
NorthWestern Energy
NWE
$4.45B
$71K ﹤0.01%
1,000
TGNA
1308
DELISTED
TEGNA Inc
TGNA
$71K ﹤0.01%
4,267
CRH icon
1309
CRH
CRH
$69.1B
$69K ﹤0.01%
1,734
HUN icon
1310
Huntsman Corp
HUN
$2B
$68K ﹤0.01%
2,821
-92
-3% -$2.13K
SBAC icon
1311
SBA Communications
SBAC
$18.6B
$68K ﹤0.01%
285
+6
+2% +$1.42K
NSANY
1312
DELISTED
NISSAN MOTOR CO LTD SPONS ADR
NSANY
$68K ﹤0.01%
5,814
+893
+18% +$10.4K
CG icon
1313
Carlyle Group
CG
$16.7B
$67K ﹤0.01%
2,100
IGF icon
1314
iShares Global Infrastructure ETF
IGF
$10.9B
$67K ﹤0.01%
+1,400
New +$65.7K
XLG icon
1315
Invesco S&P 500 Top 50 ETF
XLG
$10.4B
$67K ﹤0.01%
2,900
BSTC
1316
DELISTED
BioSpecifics Technologies Corp.
BSTC
$67K ﹤0.01%
1,191
GS.PRJ
1317
DELISTED
GOLDMAN SACHS GROUP, INC. 5.50% SER J
GS.PRJ
$67K ﹤0.01%
2,511
OC icon
1318
Owens Corning
OC
$11.5B
$66K ﹤0.01%
1,018
+786
+339% +$50.3K
SBSI icon
1319
Southside Bancshares
SBSI
$974M
$66K ﹤0.01%
1,782
+102
+6% +$3.6K
SCHA icon
1320
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$66K ﹤0.01%
3,528
-2,988
-46% -$54.1K
MDCO
1321
DELISTED
Medicines Co
MDCO
$66K ﹤0.01%
784
-3,861
-83% -$257K
CNTY icon
1322
Century Casinos
CNTY
$32.6M
$64K ﹤0.01%
8,145
+156
+2% +$1.22K
LEN icon
1323
Lennar Class A
LEN
$21.1B
$64K ﹤0.01%
1,188
PPH icon
1324
VanEck Pharmaceutical ETF
PPH
$987M
$64K ﹤0.01%
1,000
TOL icon
1325
Toll Brothers
TOL
$14.5B
$64K ﹤0.01%
1,671

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.